Dr. Rathore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Chalkstone Ave
Providence, RI 02908Phone+1 401-456-2077Fax+1 401-456-5765
Education & Training
- Roger Williams Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
- Brown UniversityResidency, Internal Medicine, 1999 - 2002
- Nehru Medical College/ R. Gandhi HS UniversityClass of 1995
Certifications & Licensure
- RI State Medical License 2004 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors Start of enrollment: 2020 Dec 07
Publications & Presentations
PubMed
- 1 citationsPrognostic Impact of Tumor Status, Nodal Status and Tumor Sidedness in Metastatic Colon CancerShiva Kumar R. Mukkamalla, Ponnandai Somasundar, Bharti Rathore
Cureus. 2020-11-11 - 29 citationsHodgkin's lymphoma therapy: past, present, and future.Bharti Rathore, Marshall E Kadin
Expert Opinion on Pharmacotherapy. 2010-11-04 - Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).Ritesh Rathore, Ariel E. Birnbaum, Bharti Rathore, Thomas A. DiPetrillo, Teresa Kennedy
Cancer Chemotherapy and Pharmacology. 2010-02-04
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: